[1] Xu WF, Xu M, Ruan CF, 2024, A Qualitative Study on the Experience of Repeated Hospitalizations of Patients with Liver Cirrhosis and Abdominal Ascites. Psychology Monthly, 19(18): 31–34.

[2] Xu XY, Ding HG, Li WG, et al., 2018, Guidelines for the Diagnosis and Treatment of Liver Cirrhosis with Abdominal Ascites and Related Complications (2017, Beijing). Chinese Journal of Gastrointestinal Endoscopy (Electronic Edition), 5(1): 1–17.

[3] Zhong PL, 2022, Clinical Observation on the Treatment of Qi Stagnation and Dampness Resistance Type Liver Cirrhosis with Abdominal Ascites by Promoting Qi Circulation, Resolving Dampness, and Draining Water Method, thesis, Guangzhou University of Chinese Medicine.

[4] Lv YH, 2020, Analysis of the Efficacy of Integrated Traditional Chinese and Western Medicine in the Treatment of Qi Stagnation and Dampness Obstruction Type Liver Cirrhosis with Abdominal Ascites. Shenzhen Journal of Integrated Traditional Chinese and Western Medicine, 30(5): 43–44.

[5] Yang XJ, Li J, Zhang GL, 2020, Evaluation of the Efficacy of Traditional Chinese Medicine Umbilical Compress Combined with Diuretics in the Treatment of Qi Stagnation and Dampness Obstruction Type Liver Cirrhosis with Abdominal Ascites. Shi Zhen Medicine and Materia Medica Research, 31(6): 1408–1410.

[6] Geng XX, 2022, Clinical Efficacy Study of Modified Linggui Fuping Decoction Combined with Warm Acupuncture and Moxibustion in the Treatment of Refractory Abdominal Ascites Caused by Hepatitis Liver Cirrhosis (cold-wet spleen type), thesis, Henan University of Chinese Medicine.

[7] Wang DN, Chen LH, Wu RH, et al., 2018, Research on the Medication Rules of Famous Old Chinese Medicine Doctors for AIDS Complicated with Liver Cirrhosis and Abdominal Ascites. Chinese General Practice, 21(4): 486–490.

[8] Lai ZY, 2019, The Effect of Clearing Heat and Draining Dampness to Treat Damp-heat Accumulation Type Liver Cirrhosis with Abdominal Ascites. Chinese Community Doctors, 35(14): 104–105.

[9] Zhu OL, Zhang YB, Wang LY, et al., 2024, Clinical Efficacy and Safety of Clearing Heat and Draining Dampness Modified Formula in the Treatment of Patients with Liver Cirrhosis and Abdominal Ascites of Damp-heat Accumulation Syndrome. World Journal of Integrated Traditional Chinese and Western Medicine, 19(11): 2251–2256.

[10] Huang L, Xie JH, Fan XL, et al., 2024, Clinical Study on the Treatment of Liver Cirrhosis with Abdominal Ascites by Lidan Xiaogu Soup Combined with Acupoint Application. Clinical Medicine Practice, 33(10): 723–726 + 758.

[11] Han HH, Liu CG, Yan YC, et al., 2023, Clinical Efficacy of Shenlong Powder Applied to The Navel Combined with Diuretics in the Treatment of Liver Cirrhosis with Abdominal Ascites and Portal Hypertension of Liver and Spleen Blood Stasis Type. Journal of Weifang Medical University, 45(6): 405–408.

[12] Li XF, Guo L, Zhang F, et al., 2023, Application of Ziwu Liuzhu Time-selecting Acupoint Application Therapy Combined with Nursing in Patients with Liver Cirrhosis and Abdominal Ascites of Spleen and Kidney Yang Deficiency Type. Guizhou Medicine, 47(7): 1150–1151.

[13] Xia KB, 2025, Analysis of the Clinical Effect of Liver Disease Therapy Instrument Navel Irradiation in the Treatment of Spleen and Kidney Yang Deficiency Type Hepatitis B Liver Cirrhosis with Abdominal Ascites. China Medical Device Information, 31(6): 60–62.

[14] Tan WT, Ling JS, Zhang HQ, et al., 2025, Effect of Jianpi Lishui Decoction Combined with Spironolactone in the Treatment of Liver Cirrhosis Abdominal Ascites of Spleen and Kidney Yang Deficiency Type. Chinese and Foreign Medical Research, 23(7): 115–119.

[15] Cui X, 2022, Observation on the Curative Effect of Zigan Bushen Lishui Recipe in the Treatment of Liver Cirrhosis Abdominal Ascites with Syndrome of Water Stagnation Due to Liver and Kidney Yin Deficiency, thesis, Shandong University of Traditional Chinese Medicine.

[16] Wang J, Wang XX, He XF, et al., 2024, Observation on the Effect of Modified Yiguanjian Combined with Western Medicine in the Treatment of Liver Cirrhosis Abdominal Ascites with Syndrome of Water Stagnation due to Liver and Kidney Yin Deficiency. Chinese and Foreign Medical Research, 3(16): 111–113.

[17] De Vincentis A, Vespasiani-Gentilucci U, Costanzo L, et al., 2021, The Multifaceted Spectrum of Liver Cirrhosis in Older Hospitalised Patients: Analysis of the REPOSI Registry. Age and Ageing, 50(2): 498–504.

[18] Li SS, Yang CQ, 2023, Diagnostic and Therapeutic Characteristics of Complications of Liver Cirrhosis with Portal Hypertension in the Elderly Population. Liver, 28(10): 1248–1251.

[19] Wang Y, 2021, Clinical Analysis of the Etiology of Abdominal Ascites in Children, thesis, Nanchang University.

[20] Cheng WQ, Zhu HD, Zhu WJ, 2023, Effects of Compound Glycyrrhizin Combined with Tenofovir Disoproxil Fumarate on Inflammatory Factors and Peripheral Blood T Cells in Active Hepatitis B Liver Cirrhosis. Naval Medical Journal, 44(2): 157–161.

[21] Hu YY, Zhang X, Wang YD, et al., 2023, Research Progress on the Treatment of Cirrhotic Ascites with Tolvaptan, an Arginine Vasopressin V2 Receptor Antagonist. Chinese Journal of Internal Medicine, 62(7): 881–884.

[22] Li YP, Chen XH, Liu YD, et al., 2013, Treatment of one Case of Hepatitis C Cirrhosis with Ascites and Severe Jaundice using Jianpi Wenshen Formula Combined with Ursodeoxycholic Acid. Continuing Medical Education, 27(1): 64–66.

[23] Shan S, Zhao LH, Ma H, 2021, Definition, Etiology, and Epidemiology of Liver Cirrhosis. Journal of Clinical Hepatobiliary Diseases, 37(1): 14–16.

[24] Li WK, Zhang MG, Chen WY, et al., 2023, Exploration of Traditional Chinese Medicine Syndromes and Clinical Indicators in 120 Cases of Alcoholic Liver Cirrhosis with Abdominal Ascites. Clinical Research of Chinese Medicine, 15(29): 114–117.

[25] Mieli-Vergani G, Vergani D, 2003, Autoimmune Liver Disease. Indian Journal of Pediatrics, 32(2): 69.

[26] Li Y, Feng WG, Guo FQ, et al., 2024, A Case of HIV Infection Complicated with Autoimmune Hepatitis-primary Biliary Cholangitis Overlap Syndrome. Chinese Journal of AIDS & STD, 30(10): 1082–1084.

[27] Wu MC, Li MD, 2011, Practical Hepatology. People’s Medical Publishing House, Beijing, 228.

[28] Wang Y, Attar BM, Gandhi S, et al., 2017, Characterization of Ascites in Cardiac Cirrhosis: The Value of Ascitic Fluid Protein to Screen for Concurrent Cardiac Cirrhosis. Scandinavian Journal of Gastroenterology, 52(8): 898–903.

[29] Zhang H, 2018, Causes and Five Precursor Manifestations of “Liver Cirrhosis”. Everyone’s Health, 2018(7): 59.

[30] Chen YJ, 2024, What to do about Liver Cirrhosis with Abdominal Ascites? What are the Precautions? Health Must-Read, 2024(15): 41–42.

[31] Qi XL, 2020, Full-course Management of Portal Hypertension: From Complexity to Simplicity. Chinese Journal of Hepatology, 28(9): 721–723.

[32] Zhang T, 2021, Effects of Danshen Injection Combined with Human Albumin on Liver Function and Complications in Patients with Refractory Hepatic Abdominal ascites. Practical Clinical Medicine of Integrated Traditional Chinese and Western Medicine, 21(18): 127–128.

[33] Zhu TY, Lan KH, 2020, Clinical Analysis of the Treatment of Liver Cirrhosis with Refractory Hepatic Abdominal Ascites. Jilin Medical Journal, 41(6): 1461–1462.

[34] Li S, Tao YY, Xing F, et al., 2019, Effect of Xiaozhang Plaster on Cirrhotic Abdominal Ascites and its Influence on Renin-angiotensin-aldosterone system. Journal of Clinical Hepatology, 35(7): 1496–1500.

[35] Zhao YN, Xie Y, 2024, Study on the Predictive Efficacy of Different Inflammatory Factors for Cirrhosis Abdominal Ascites Complicated with Abdominal Infection. China Medical Engineering, 32(4): 8–12.

[36] Shen GR, Shen FT, Cai YM, 1975, Pathogenesis and Treatment Progress of Cirrhosis Abdominal Ascites. Foreign Medical References (Internal Medicine), 1975(12): 549–555.

[37] Lan T, Chen M, Tang C, et al., 2024, Recent Developments in the Management of Ascites in Cirrhosis. United European Gastroenterology Journal, 12(2): 261–272.

[38] Mostafa MS, El-Seidi EA, Kassem AM, et al., 2011, Detection of Ascitic Fluid Infections in Patients with Liver Cirrhosis and Ascites. Arab Journal of Gastroenterology, 12(1): 20–24.

[39] Gao N, Nie M, Jia YH, 2024, Study on the Effects of Rifaximin on Inflammatory Factors and Intestinal Flora in Patients with Cirrhosis and Abdominal Ascites. China Health Standard Management, 15(17): 154–157.

[40] Zhang ZL, 2022, Study on the Anti-fibrotic Effect and Mechanism of Human Adipose-derived Mesenchymal Stem Cell Exosomes, thesis, University of Electronic Science and Technology of China.

[41] Albillos A, de Gottardi A, Rescigno M, 2019, The Gut-Liver Axis in Liver Disease: Pathophysiological Basis for Therapy. Journal of Hepatology, 72(3): 558–577.

[42] Humphry N, 2022, Recent Findings in the Gut-Liver Axis and Associated Disease Therapy. European Medical Journal of Hepatology, 2022(10): 4–16.

[43] Dicheva D, Andreev D, 2022, Pathogenetic and Clinical Significance of the Gut-Liver Microbiota Axis. Medical Council (Meditsinskiy sovet), 2022(7): 69–75.

[44] Fu ZD, Cui JY, 2017, Remote Sensing between Liver and Intestine: Importance of Microbial Metabolites. Current Pharmacology Reports, 3(3): 101–113.

[45] Wang L, Cao ZM, Zhang LL, et al., 2022, The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective. Frontiers in Immunology, 2022(13): 923599.

[46] Chinese Medical Association Liver Disease Branch, 2019, Guidelines for the Diagnosis and Treatment of Liver Cirrhosis. Chinese Journal of Hepatology, 27(11): 846–865.

[47] Tung BY, Kowdley KV, 1997, Liver Transplantation for Hemochromatosis, Wilson’s Disease, and other Metabolic Disorders. Clinical Liver Disease, 1(2): 341–360.

[48] Chinese Medical Association Liver Disease Branch, 2018, Guidelines for the Diagnosis and Treatment of Abdominal Ascites and Related Complications in Liver Cirrhosis. Journal of Practical Hepatology, 21(1): 21–31.